These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38249137)

  • 21. Cannabis use during treatment for alcohol use disorders predicts alcohol treatment outcomes.
    Subbaraman MS; Metrik J; Patterson D; Swift R
    Addiction; 2017 Apr; 112(4):685-694. PubMed ID: 27865015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurofeedback training for alcohol dependence versus treatment as usual: study protocol for a randomized controlled trial.
    Cox WM; Subramanian L; Linden DE; Lührs M; McNamara R; Playle R; Hood K; Watson G; Whittaker JR; Sakhuja R; Ihssen N
    Trials; 2016 Oct; 17(1):480. PubMed ID: 27716290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
    Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
    JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid antagonists for alcohol dependence.
    Srisurapanont M; Jarusuraisin N
    Cochrane Database Syst Rev; 2000; (3):CD001867. PubMed ID: 10908513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial association of abstinent remission from alcohol use disorder in first-degree relatives of alcohol-dependent treatment-seeking probands.
    McCutcheon VV; Schuckit MA; Kramer JR; Chan G; Edenberg HJ; Smith TL; Bender AK; Hesselbrock V; Hesselbrock M; Bucholz KK
    Addiction; 2017 Nov; 112(11):1909-1917. PubMed ID: 28556494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolite levels in the brain reward pathway discriminate those who remain abstinent from those who resume hazardous alcohol consumption after treatment for alcohol dependence.
    Durazzo TC; Pathak V; Gazdzinski S; Mon A; Meyerhoff DJ
    J Stud Alcohol Drugs; 2010 Mar; 71(2):278-89. PubMed ID: 20230726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a 1-year short message service in detoxified alcohol-dependent patients: a multi-center, open-label randomized controlled trial.
    Lucht M; Quellmalz A; Mende M; Broda A; Schmiedeknecht A; Brosteanu O; Höppner-Buchmann J; Langosch J; Stuppe M; Schomerus G; Klauer T; Grabe HJ; Freyberger HJ; John U; Meyer C
    Addiction; 2021 Jun; 116(6):1431-1442. PubMed ID: 33155711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alcohol dependence severity determines the course of treatment-seeking patients.
    Yoshimura A; Kimura M; Matsushita S; Yoneda JI; Maesato H; Komoto Y; Nakayama H; Sakuma H; Yumoto Y; Takimura T; Tohyama T; Iwahara C; Mizukami T; Yokoyama A; Higuchi S
    Alcohol Clin Exp Res; 2021 Nov; 45(11):2335-2346. PubMed ID: 34585408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of drinking goals at treatment entry on longitudinal alcohol use patterns among adults with alcohol dependence.
    Mowbray O; Krentzman AR; Bradley JC; Cranford JA; Robinson EA; Grogan-Kaylor A
    Drug Alcohol Depend; 2013 Sep; 132(1-2):182-8. PubMed ID: 23433899
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences between abstinent and non-abstinent individuals in recovery from alcohol use disorders.
    Subbaraman MS; Witbrodt J
    Addict Behav; 2014 Dec; 39(12):1730-5. PubMed ID: 25117850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Counselling for Alcohol Problems (CAP), a lay counsellor-delivered brief psychological treatment for harmful drinking in men, in primary care in India: a randomised controlled trial.
    Nadkarni A; Weobong B; Weiss HA; McCambridge J; Bhat B; Katti B; Murthy P; King M; McDaid D; Park AL; Wilson GT; Kirkwood B; Fairburn CG; Velleman R; Patel V
    Lancet; 2017 Jan; 389(10065):186-195. PubMed ID: 27988144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motivational support intervention to reduce smoking and increase physical activity in smokers not ready to quit: the TARS RCT.
    Taylor AH; Thompson TP; Streeter A; Chynoweth J; Snowsill T; Ingram W; Ussher M; Aveyard P; Murray RL; Harris T; Green C; Horrell J; Callaghan L; Greaves CJ; Price L; Cartwright L; Wilks J; Campbell S; Preece D; Creanor S
    Health Technol Assess; 2023 Mar; 27(4):1-277. PubMed ID: 37022933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with favorable drinking outcome 12 months after hospitalization in a prospective cohort study of inpatients with unhealthy alcohol use.
    Bertholet N; Cheng DM; Palfai TP; Saitz R
    J Gen Intern Med; 2010 Oct; 25(10):1024-9. PubMed ID: 20480250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
    Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
    Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expressed Emotions and Coping among Relapsed Persons with Alcohol Dependence Syndrome: A Comparative Study.
    Shanmugam B; Das B; Bhattacharjee D; Ezhumalai S
    Indian J Ment Health; 2021; 8(4):429-434. PubMed ID: 35036570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Social Support and Treatment Outcome in Alcohol Dependence Syndrome in Armed Forces.
    Dixit S; Chauhan VS; Azad S
    J Clin Diagn Res; 2015 Nov; 9(11):VC01-VC05. PubMed ID: 26676246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population.
    Hasin DS; Wall M; Witkiewitz K; Kranzler HR; Falk D; Litten R; Mann K; O'Malley SS; Scodes J; Robinson RL; Anton R;
    Lancet Psychiatry; 2017 Jun; 4(6):469-476. PubMed ID: 28456501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 10 add-on HF-rTMS treatment sessions on alcohol use and craving among detoxified inpatients with alcohol use disorder: a randomized sham-controlled clinical trial.
    Hoven M; Schluter RS; Schellekens AF; van Holst RJ; Goudriaan AE
    Addiction; 2023 Jan; 118(1):71-85. PubMed ID: 35971295
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pilot Cohorts for Development of Concurrent Mobile Treatment for Alcohol and Tobacco Use Disorders.
    Medenblik AM; Calhoun PS; Maisto SA; Kivlahan DR; Moore SD; Beckham JC; Wilson SM; Blalock DV; Dedert EA
    Subst Abuse; 2021; 15():11782218211030524. PubMed ID: 34552330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.